发明名称 Oral administration of a compound for blocking the 5-HT2A receptor, in the treatment of symptoms resulting from testosterone deficiency
摘要 Use of a compound for blocking the 5-HT2A receptor and intrinsically working on the receptor by oral means, in the treatment of symptoms resulting from orchidectomy, plasma-testosterone lowering or testosterone receptor blocking compounds is claimed.
申请公布号 NL1012954(C2) 申请公布日期 2001.03.05
申请号 NL19991012954 申请日期 1999.09.01
申请人 DR. MARCEL DAVID WALDINGER;DR. DAVE HENRY SCHWEITZER 发明人 DR. MARCEL DAVID WALDINGER;DR. DAVE HENRY SCHWEITZER
分类号 A61K31/00;A61K31/55;(IPC1-7):A61K31/55;A61P5/04;A61P25/24 主分类号 A61K31/00
代理机构 代理人
主权项
地址